Schizophrenia and co-occurring substance use disorder.
Green
Alan I
AI
Department of Psychiatry, Dartmouth Medical School, Hanover, NH, USA.
Drake
Robert E
RE
Brunette
Mary F
MF
Noordsy
Douglas L
DL
D000077443:Acamprosate; D000328:Adult; D019973:Alcohol-Related Disorders / Q000188:drug therapy / Q000453:epidemiology; D014150:Antipsychotic Agents / Q000627:therapeutic use; D015897:Comorbidity; D017831:Diagnosis, Dual (Psychiatry); D004221:Disulfiram / Q000627:therapeutic use; D006703:Ill-Housed Persons / Q000523:psychology; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000627:therapeutic use; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D013654:Taurine / Q000031:analogs & derivatives / Q000627:therapeutic use
D014150:Antipsychotic Agents; D013654:Taurine; D009271:Naltrexone; D000077443:Acamprosate; D004221:Disulfiram